Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000875928 | SCV001018417 | likely benign | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV000875928 | SCV001468487 | uncertain significance | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7 | 2020-08-12 | criteria provided, single submitter | clinical testing | IFIH1 NM_022168.3 exon 15 p.Gln955Glu (c.2863C>G): This variant has not been reported in the literature but is present in 0.7% (82/10370) of Ashkenazi Jewish alleles, including 1 homozygote, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-163124024-G-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:705603). This variant amino acid Glutamic Acid (Glu) is present in several species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Center for Genomics, |
RCV003224484 | SCV003920038 | uncertain significance | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7; Immunodeficiency 95 | 2021-03-30 | criteria provided, single submitter | clinical testing | IFIH1 NM_022168.3 exon 15 p.Gln955Glu (c.2863C>G): This variant has not been reported in the literature but is present in 0.7% (82/10370) of Ashkenazi Jewish alleles, including 1 homozygote, in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/2-163124024-G-C?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:705603). This variant amino acid Glutamic Acid (Glu) is present in several species and is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ce |
RCV001573673 | SCV004147073 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | IFIH1: BP4 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573673 | SCV001799900 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001573673 | SCV001932342 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573673 | SCV001974025 | likely benign | not provided | no assertion criteria provided | clinical testing |